Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neutropenia 1Infections 1

Interventions

plerixafor 2Voriconazole 2Levofloxacin 2threonic acid 1amphotericin B, deoxycholate drug combination 1Polymerase Chain Reaction 1Nystatin 1Magnesium Sulfate 1Interferon-gamma 1Immunoenzyme Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1ER 30346 1Cone-Beam Computed Tomography 1Cefepime 1Caspofungin 1Bronchoscopy 1Bronchoalveolar Lavage 1Bevacizumab 1Anidulafungin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Infections × Anidulafungin × Clear all
NCT00068471 2013-06-19

Anidulafungin in Treating Immunocompromised Children With Neutropenia

National Cancer Institute (NCI)

Phase 1/2 Completed

Infections, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡